Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2

Emilie Pihan1, Roberto F Delgadillo, Michelle L Tonkin

  • 1Institut de Pharmacologie Moléculaire et Cellulaire, Université de Nice Sophia-Antipolis, CNRS, UMR 7275, 660, Route des Lucioles, Sophia Antipolis, 06560, Valbonne, France.

Insights

Researchers identified a potential new antimalarial drug candidate by computationally screening millions of compounds to inhibit the Plasmodium falciparum Apical Membrane Antigen 1 (PfAMA1)-Rhoptry Neck Protein 2 (RON2) interaction, crucial for malaria parasite invasion.

Area of Science:

  • Malariology
  • Parasitology
  • Drug Discovery

Background:

  • The Plasmodium falciparum parasite invades red blood cells via a Moving Junction (MJ).
  • The MJ complex involves parasite protein Apical Membrane Antigen 1 (PfAMA1) and host-cell-embedded Rhoptry Neck Protein 2 (RON2).
  • PfAMA1 has a hydrophobic groove that binds RON2 and inhibitory peptides, representing a potential drug target.

Purpose of the Study:

  • To identify competitive inhibitors of the PfAMA1-RON2 interaction.
  • To explore the druggability of PfAMA1 as an antimalarial target.
  • To develop and validate methods for screening PfAMA1-RON2 inhibitors.

Main Methods:

  • Virtual screening of eight million compounds against the PfAMA1 crystal structure using molecular docking.
  • Consensus approach to select potential inhibitor candidates.
  • Fluorescence anisotropy assay using a modified inhibitory peptide to validate compound efficacy.

Main Results:

  • A virtual screen identified several inhibitor candidates targeting the PfAMA1-RON2 interaction.
  • Experimental validation confirmed one compound significantly inhibited the PfAMA1-RON2 interaction.
  • The study demonstrated the feasibility of screening for PfAMA1-RON2 inhibitors.

Conclusions:

  • The PfAMA1-RON2 interaction is a druggable target for antimalarial drug development.
  • Computational and biophysical methods can effectively identify inhibitors of this interaction.
  • This research provides a foundation for developing new antimalarial therapies.